Monthly Archives: November 2017


It has recently been announced that the Duke University Medical Center has received permission, from the FDA, to expand the access of cord blood clinical trials for conditions like autism spectrum disorder and cerebral palsy. Children who have these neurological disorders are now able to receive therapy, regardless of whether they qualify for a targeted… Read more »